Novo Nordisk (NVO) closed at $38.31 in the latest trading session, marking a -1.03% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.17%. Elsewhere, the Dow saw a downswing of 0.26%, while the tech-heavy Nasdaq depreciated by 0.09%. The drugmaker's shares have seen a decrease of 14.6% over the last month, not keeping up with the Medical sector's loss of 0.67% and the S&P 500's loss of 0.24%. The investment community will be paying close attention to the earnings performance of Novo Nordisk in its upcoming release. It is anticipated that the company will report an EPS of $0.81, marking a 20.59% fall compared to the same quarter of the previous year.
Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.